Ipsen sells PregLem shares to Gedeon Richter
This article was originally published in Scrip
Executive Summary
Ipsen has sold its shares in PregLem to Gedeon Richter, clearing the way for the Hungarian firm's acquisition of the private Swiss biopharmaceutical firm.